Detalhe da pesquisa
1.
Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level.
Br J Cancer
; 129(10): 1692-1705, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740038
2.
Expression of Lamin A/C in early-stage breast cancer and its prognostic value.
Breast Cancer Res Treat
; 174(3): 661-668, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610489
3.
The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
J Obstet Gynaecol
; 39(4): 522-528, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712414
4.
The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis.
Breast Cancer Res
; 20(1): 11, 2018 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29402299
5.
Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer.
Breast Cancer Res Treat
; 158(2): 287-95, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380874
6.
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.
Breast Cancer Res Treat
; 157(1): 65-75, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27116185
7.
Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.
Malays J Pathol
; 38(2): 83-92, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27568664
8.
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
Br J Cancer
; 112(12): 1929-37, 2015 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25989275
9.
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.
Br J Cancer
; 112(2): 283-9, 2015 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25422911
10.
Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response.
Br J Cancer
; 112(5): 901-11, 2015 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25688741
11.
Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification.
Breast Cancer Res Treat
; 151(2): 325-33, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953687
12.
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
Br J Cancer
; 110(7): 1688-97, 2014 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619074
13.
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
Ann Oncol
; 25(8): 1536-43, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24915873
14.
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers.
Br J Cancer
; 109(7): 1886-94, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24008658
15.
A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative.
Ann Oncol
; 24(1): 47-53, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22847811
16.
Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
Breast Cancer Res Treat
; 137(1): 127-37, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23208589
17.
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.
Br J Cancer
; 107(5): 800-7, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22850554
18.
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
Breast Cancer Res Treat
; 135(2): 555-69, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22842985
19.
Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
Ann R Coll Surg Engl
; 104(5): 361-366, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939848
20.
Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.
Breast Cancer Res Treat
; 159(1): 199, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27447877